Ascentage Pharma Group International vs Schrodinger
AAPG and SDGR side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AAPG and SDGR compare
Schrodinger grew revenue faster over the last twelve months (4.8% versus −41.5% for Ascentage Pharma Group International).
Schrodinger keeps more of each dollar of sales as profit, with a net margin of −22.0% compared with −216% at Ascentage Pharma Group International.
Schrodinger scores higher on the StockData Score (11 against 3 for Ascentage Pharma Group International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AAPG | SDGR |
|---|---|---|
| Size and price | ||
| Market cap | – | $2.2B |
| Share price | $14.62 | $29.53 |
| Change, 1 year | −55.6% | 64.2% |
| Change, 5 years | – | −27.6% |
| Beta (5Y) | 0.79 | 1.84 |
| Employees | 767 | 850 |
| StockData Score | ||
| Total score | 3 | 11 (better) |
| Valuation score | 0 | 0 |
| Growth score | 1 | 3 (better) |
| Performance score | 1 | 3 (better) |
| Health score | 1 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 8.2× |
| P/B | – | 7.3× |
| FCF yield | – | −5.3% |
| Fair value | – | $17.34 |
| Margin of safety | – | −70.3% |
| Growth | ||
| Revenue growth (TTM) | −41.5% | 4.8% (better) |
| Revenue growth, 5Y average | – | 18.8% |
| Profitability | ||
| Gross margin | 91.5% (better) | 58.5% |
| Operating margin | – | −49.6% |
| Net margin | −216% | −22.0% (better) |
| FCF margin | −209% | −43.4% (better) |
| Return on equity | −156% | −19.0% (better) |
| Financial health | ||
| Debt / equity | 1.50 (better) | 0.00 |
| Current ratio | 1.79 | 2.75 (better) |
| Altman Z-score | – | 2.91 |
| Piotroski F-score | – | 5 |
| Dividends and buybacks | ||
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | 0.00% | 86.5% |
| Held by insiders | 13.0% | 3.3% |
| Insider net buying, 12 months | – | −$4.2M |
| Superinvestors holding | – | 1 |
| Short interest, % of float | – | 13.5% |
Go deeper
- AAPG stock overview
- AAPG income statement
- AAPG valuation and score
- SDGR stock overview
- SDGR income statement
- SDGR valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.